P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL

• Huafeng Wang,
• Min Yang,
• Hongyan Tong,
• Yinjun Lou,
• Honghu Zhu,
• Yue Han,
• Jiejin Qian,
• Liping Mao,
• Chunmei Yang,
• Ying Lu,
• Xinping Zhou,
• Lihong Shou,
• Haitao Meng,
• De Zhou,
• Wenjuan Yu,
• LI LI,
• Jie Jin

Affiliations

Huafeng Wang

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Min Yang

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Hongyan Tong

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Yinjun Lou

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Honghu Zhu

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Yue Han

2 The First Affiliated Hospital of Suzhou University, Department of Hematology, Suzhou, China

Jiejin Qian

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Liping Mao

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Chunmei Yang

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Ying Lu

3 The Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, China

Xinping Zhou

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Lihong Shou

4 HUZHOU CENTRAL HOSPITAL, Department of Hematology, Huzhou

Haitao Meng

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

De Zhou

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Wenjuan Yu

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

LI LI

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China

Jie Jin

1 the First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, Hangzhou, China